These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


308 related items for PubMed ID: 23020540

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Update on the treatment of diabetic retinopathy.
    Yam JC, Kwok AK.
    Hong Kong Med J; 2007 Feb; 13(1):46-60. PubMed ID: 17277392
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Management of diabetic retinopathy: could lipid-lowering be a worthwhile treatment modality?
    Dodson PM.
    Eye (Lond); 2009 May; 23(5):997-1003. PubMed ID: 19169236
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diabetic retinopathy and blockade of the renin-angiotensin system: new data from the DIRECT study programme.
    Wright AD, Dodson PM.
    Eye (Lond); 2010 Jan; 24(1):1-6. PubMed ID: 19648902
    [Abstract] [Full Text] [Related]

  • 12. Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.
    Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM, UK Prospective Diabetes Study Group.
    Arch Ophthalmol; 2004 Nov; 122(11):1631-40. PubMed ID: 15534123
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Medical management of diabetic retinopathy.
    Sjølie AK, Møller F.
    Diabet Med; 2004 Jul; 21(7):666-72. PubMed ID: 15209756
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
    Hogeboom van Buggenum IM, Polak BC, Reichert-Thoen JW, de Vries-Knoppert WA, van Hinsbergh VW, Tangelder GJ.
    Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Medical management for the prevention and treatment of diabetic macular edema.
    Kiire CA, Porta M, Chong V.
    Surv Ophthalmol; 2013 Feb; 58(5):459-65. PubMed ID: 23969020
    [Abstract] [Full Text] [Related]

  • 20. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 Feb; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.